Jubilant Pharmova Ltd.
BSE: 530019 | Sector: Health care |
NSE: JUBLPHARMA | ISIN Code: INE700A01033 |
BSE 00:00 | 27 Jan | 338.10 |
-8.25 (-2.38%) |
OPEN
347.15 |
HIGH
349.50 |
LOW
329.40 |
NSE 15:59 | 27 Jan | 337.65 |
-9.00 (-2.60%) |
OPEN
345.00 |
HIGH
350.05 |
LOW
331.05 |
OPEN | 347.15 |
PREVIOUS CLOSE | 346.35 |
VOLUME | 12565 |
52-Week high | 555.00 |
52-Week low | 305.20 |
P/E | 58.70 |
Mkt Cap.(Rs cr) | 5,386 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Jubilant Pharmova Ltd. (JUBLPHARMA) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 725.73 | 2709.50 | 3139.90 | 3438.61 | 3306.33 |
Other Income | 126.16 | 47.88 | 173.23 | 78.00 | 46.21 |
Total Income | 851.89 | 2757.38 | 3313.13 | 3516.61 | 3352.54 |
Total Expenditure | 719.27 | 2282.44 | 2770.69 | 3117.74 | 2767.08 |
Operating Profit | 132.62 | 474.94 | 542.44 | 398.87 | 585.46 |
Interest | 10.99 | 101.80 | 136.20 | 128.96 | 135.17 |
Gross Profit | 121.63 | 373.14 | 406.24 | 269.91 | 450.29 |
Depreciation | 36.91 | 99.97 | 107.40 | 86.48 | 82.60 |
PBT | 84.72 | 273.17 | 298.84 | 183.43 | 367.69 |
Tax | 14.28 | 45.44 | -22.30 | 35.80 | 104.25 |
Net Profit/(Loss) | 80.49 | 214.48 | 321.14 | 147.63 | 263.44 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | -1.70 | 0.00 | 0.00 |
Profit After Exceptional Items | 80.49 | 214.48 | 322.84 | 147.63 | 263.44 |
Equity Share Capital | 15.93 | 15.93 | 15.93 | 15.93 | 15.93 |
Reserves Excluding Revaluation Reserves | 2423.14 | 1266.52 | 2591.37 | 2324.38 | 2233.45 |
EPS | |||||
Basic EPS | 5.05 | 13.47 | 20.16 | 9.27 | 16.54 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Jubilant Pharmova:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices